Roy Herbst, MD, PhD, on Why It Is an ‘Exciting Time’ in Oncology and Hematology

(MedPage Today) — At the recent American Society of Clinical Oncology (ASCO) meeting, Roy Herbst, MD, PhD, of Yale Cancer Center in New Haven, Connecticut, reflected on how emerging innovations — from bispecific T-cell engagers to moving the…